Restore Vision Inc
Light at the End of the Tunnel
Kobe, United States · Founded 2019 · $2.8M raised
- Headquarters
- Kobe
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- restore-vis.com
- Total Funding
- $2.8M
- Last Round
- $2.8M Venture RoundApr 2026
- Rounds
- 3
About
Restore Vision Inc. is a clinical-stage gene therapy company developing transformative treatments for inherited retinal diseases (IRDs) such as retinitis pigmentosa. Its lead program RV-001 uses a gene-agnostic approach — Chimeric opsin technology — to restore light sensitivity regardless of the underlying genetic mutation. The company is currently conducting Phase I/II clinical trials.
Summary
Restore Vision Inc is a Healthcare company based in Kobe, United States, founded in 2019. It has raised $2.8M in total across 3 rounds, most recently a $2.8M Venture Round round in Apr 2026. Investors include Shionogi, Remiges Ventures and ANRI.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...